Ken Wen

Title: Ken Wen: Innovator in Stroke Treatment

Introduction

Ken Wen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical research, particularly in the area of stroke treatment. His innovative work focuses on the protective effects of curcumin against hemorrhagic stroke injury.

Latest Patents

Ken Wen holds a patent for his research titled "Protective effects of curcumin against hemorrhagic stroke injury." This patent discloses compounds, compositions, and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer, or conditions associated with damaged cells, activated lymphocytes, or microbial products. The disclosed compounds are curcumin analogs, which possess anti-inflammatory and antioxidant properties. These properties help reduce AP-1 and NF-κB activity, making them valuable in medical applications.

Career Highlights

Throughout his career, Ken Wen has worked with esteemed institutions such as Augusta University Research Institute, Inc. and East China Normal University. His research has garnered attention for its potential impact on treating serious medical conditions.

Collaborations

Ken has collaborated with notable professionals in his field, including Cargill H Alleyne, Jr. and Krishnan M Dhandapani. These collaborations have further enriched his research and contributed to advancements in medical science.

Conclusion

Ken Wen is a pioneering inventor whose work in curcumin analogs offers promising avenues for treating hemorrhagic stroke and related conditions. His contributions to medical research highlight the importance of innovation in improving health outcomes.